🇰🇷 MAPROTILINE in South Korea

MAPROTILINE (MAPROTILINE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

MAPROTILINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in South Korea

Frequently asked questions

Is MAPROTILINE approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for MAPROTILINE in South Korea?

Marketing authorisation holder not available in our data.